The USGA and The R&A have unveiled a preview of proposed new Rules of Golf, as part of a joint initiative to modernize the Rules and make them easier to understand and apply.
The online release of this preview begins a six-month feedback and evaluation period during which all golfers worldwide can learn about the proposed changes and provide input before they are finalized in 2018 and take effect January 1, 2019.
The announcement follows a comprehensive review process that began in 2012 with a working group of key USGA and R&A Rules administrators, professional tour officials and other Rules experts. While the Rules are revised every four years, this is the first fundamental review since 1984, and was established to ensure the Rules fit the needs of today’s game and the way it is played around the world.
To view the multimedia release go to:
https://www.multivu.com/players/English/8011851-usga-randa-proposed-changes-to-golf-rules/
As part of its longstanding commitment to Africa, Johnson & Johnson today announced the launch of the Africa Innovation Challenge, an initiative to support Africa’s vibrant and growing innovation ecosystem and to help develop important and locally sustainable consumer health solutions. The challenge is the latest initiative in the company’s comprehensive approach to advancing health and innovation worldwide. The Johnson & Johnson Family of Companies’ presence in Africa dates back more than 80 years and includes business operations, public health programs and corporate citizenship.
“Through the Africa Innovation Challenge, we have the opportunity to support the continent’s top entrepreneurs through mentorship and other resources, and by working together with local talent, to bring forward new solutions to local health care challenges,” said Paul Stoffels, M.D., Executive Vice President and Chief Scientific Officer, Johnson & Johnson.
To view the multimedia release go to:
http://www.multivu.com/players/English/7967451-jnj-africa-innovation-challenge/
Oklahoma State University (OSU) and the New York Philharmonic announced a residency partnership marking the opening of the new McKnight Center for the Performing Arts at OSU in October, 2019. The partnership is made possible in part by the visionary $25 million programming gift to OSU by alumni Billie and Ross McKnight. The McKnights’ gift established a program endowment to benefit all students, faculty and the Stillwater community by bringing top-tier residency programs and performances to OSU.
In addition to multiple New York Philharmonic performances at the McKnight Center conducted by future New York Philharmonic Music Director Jaap van Zweden, the residency partnership will include educational opportunities for OSU students with Philharmonic musicians and management, such as masterclasses, audition workshops and lectures. Every season the Philharmonic reaches millions of people through concerts at Lincoln Center in New York, worldwide tours, educational activities and outreach. The partnership with OSU adds to the Philharmonic’s growing list of educational partnerships throughout the U.S. and world, which includes the University Musical Society at the University of Michigan and New York Philharmonic Global Academy partnerships with Santa Barbara’s Music Academy of the West, The Shepherd School at Rice University and the Shanghai Symphony Orchestra.
To view the multimedia release go to:
http://www.multivu.com/players/English/7932451-osu-mcknight-new-york-philharmonic/
Breast cancer now represents one in four of all cancers in women worldwide and touches lives every day. While experiences with the disease may vary, the desire to defeat breast cancer is universal. This year, in honor of a shared vision for a world without this disease, The Estée Lauder Companies’ Breast Cancer Awareness (BCA) Campaign celebrates the power of global solidarity by encouraging people around the world to “Take Action Together to Defeat Breast Cancer.” The 2016 BCA Campaign invites women, men and families to draw inspiration from one another and unite in action on BCAcampaign.com and social media, while supporting lifesaving breast cancer research.
Over the past two decades, The Estée Lauder Companies’ BCA Campaign, launched by the late Evelyn H. Lauder, co-creator of the Pink Ribbon and founder of the Breast Cancer Research Foundation® (BCRF), has been a leading voice for breast cancer awareness around the world, igniting a global movement that has helped save millions of lives and fund innovative breast cancer research. Today, The BCA Campaign is active in more than 70 countries and has raised more than $65 million to support global research, education and medical services, with more than $50 million funding 200 BCRF medical research grants worldwide over the past 22 years. These funds help accelerate critical research across wide-ranging areas such as tumor biology, heredity and ethnicity, lifestyle and prevention, treatment, survivorship and metastasis. Around the world, The BCA Campaign partners with more than 60 breast cancer organizations focused on breast cancer research, education and medical services. This year, The BCA Campaign is committed to raising $6 million in support of its mission to defeat breast cancer through education and medical research.
To view the multimedia release go to:
http://www.multivu.com/players/English/7935851-estee-lauder-bca-campaign-2016/
The Prostate Cancer Foundation (PCF) announces the launch of the “Step Up for Blue” Campaign for Prostate Cancer Awareness Month. The campaign honors the millions of men and their families touched by prostate cancer worldwide.
“Step Up for Blue” focuses on elevating critical issues to inspire, energize, and accelerate actions that lead to greater awareness, new therapies, and fewer deaths from prostate cancer. It will run through the duration of September.
To view the multimedia release go to:
http://www.multivu.com/players/English/7729253-pcf-step-up-for-blue-prostate-cancer/
Tektronix, a leading worldwide provider of measurement solutions, today introduced the TBS2000, a next generation basic oscilloscope featuring the longest record length and largest display in its class for faster signal evaluation and troubleshooting. This latest addition to the Tektronix portfolio puts expanded capabilities, including the ability to use a wide range of Tektronix probes, into the hands of budget-constrained design engineers and educators.
“Building on the success of the TDS2000 Series, the most widely used oscilloscope in the world, the new TBS2000 gives our customers a level of design insight previously not available in this class of instrument,” said Jeff Yost, director, Basic Oscilloscopes, Tektronix. “The new instrument also sets a new standard for usability with features like a large display for easy signal visualization and a comprehensive set of automatic waveform measurements that are coupled with graphical explanations to help engineers better understand their measurements.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7724651-tektronix-tbs2000-series-oscilloscope/
On Thursday, July 28, the Estate of Michael Jackson teamed up with Michael Jackson ONE by Cirque du Soleil and Mandalay Bay to pay tribute to the King of Pop as they unveiled his iconic HIStory Statue. Featured on the cover of his world-famous album HIStory: Past, Present and Future Book 1, which became the best selling multiple disc album worldwide, the HIStory Statue is the third piece of memorabilia to be loaned by the Estate for display on the Mandalay Bay property.
The highly anticipated unveiling ceremony took place in the Main Lobby of Mandalay Bay, where fans had the opportunity to witness the live reveal of this historic sculpture. To welcome the piece, members from the cast of Michael Jackson ONE delivered a never-before-seen performance created especially for this event, dazzling the audience as they performed to “SCREAM,” the first single from the HIStory album. Following the performance, fans were able to meet and take photos with those cast members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7891751-cirque-de-soleil-michael-jackson-one/
Abbott announced today that the U.S. Food and Drug Administration has approved the company’s Absorb bioresorbable heart stent, making the first-of-its-kind medical device commercially available to treat people with coronary artery disease in the United States.
Absorb is the only fully dissolving stent approved for the treatment of coronary artery disease, which affects 15 million people in the United States and remains a leading cause of death worldwide, despite decades of therapeutic advances. While stents are traditionally made of metal, Abbott’s Absorb stent is made of a naturally dissolving material, similar to dissolving sutures. Absorb disappears completely in approximately three years, after it has done its job of keeping a clogged artery open and promoting healing of the treated artery segment. By contrast, metal stents are permanent implants that restrict vessel motion for the life of the person treated.
To view the multimedia release go to:
http://www.multivu.com/players/English/7826651-abbott-fda-approval-stent/
February 24 -- There are more than one billion cars on the road worldwide today, and only one tenth of one percent of them have a plug. OPEC contends that even in the year 2040, EVs will make up just one percent. But don't be so sure. By 2020, some electric cars and SUVs will be faster, safer, cheaper, and more convenient than their gasoline counterparts. What if people just stop buying oil? In the first episode of our animated series, Sooner Than You Think, Bloomberg's Tom Randall does the math on when oil markets might be headed for the big crash.
Like this video? Subscribe to Bloomberg Business on YouTube: http://www.youtube.com/Bloomberg
Eli Lilly and Company (NYSE: LLY) will commemorate its 140th anniversary today with activities at Lilly locations worldwide, including a ceremony to unveil a statue dedicated to founder Colonel Eli Lilly at global headquarters in Indianapolis.
Over 14 decades, the organization has contributed more than 100 medicines and significant medical advances, such as the first commercially available insulin, manufacturing and global distribution of the Salk polio vaccine and mental health breakthroughs such as anti-depressant Prozac® (fluoxetine). Today Lilly continues to progress its most robust pipeline in history with dozens of potential new medicines in mid- to late-stage development for cancer, diabetes, autoimmune disease, pain and Alzheimer’s disease.
“As Lilly celebrates 140 years, we’re keeping the vision of our founder alive – from our dedication in the lab to our impact in the community,” said John C. Lechleiter, Ph.D., Lilly chairman, president and chief executive officer, who began his career at Lilly as a chemist in 1979. “Colonel Eli Lilly started this company to put science to work fighting disease and encouraged his successors to ‘take what you find here and make it better and better.’ That vision pushes us daily to honor Colonel Lilly’s legacy and continue in our quest to discover new medicines to help make life better.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7809951-eli-lilly-and-company-140th-anniversary/
An international survey conducted by GSK and released for World Meningitis Day shows gaps in the knowledge parents feel they have about meningococcal disease and its potential consequences. Almost 7 in 10 parents said they don’t know enough about the different strains of meningococcal disease and the potential damage they can cause. On average, more than half of parents were either unsure or unaware that there are different types of bacteria that cause the disease.
The survey of 5,000 parents in Brazil, Canada, Germany, Italy and Portugal also shows that out of a list of 14 vaccine-preventable diseases, meningococcal disease is considered by many parents to pose a top three health risk to their children. Fifty-seven percent listed meningococcal disease among the top three health conditions they considered of greatest risk to children followed by Hepatitis B at 34 percent, pneumococcal disease at 27 percent, polio at 25 percent, tetanus at 20 percent and pertussis at 17 percent.
A sudden, potentially life-threatening illness, meningococcal disease kills on average one person every eight minutes worldwide. It typically manifests as bacterial meningitis – an infection of the membrane around the brain and spine; or bacteraemia – a bloodstream infection. The disease progresses rapidly and it can lead to death within 24-48 hours of the first symptoms; globally up to 1 in 10 of those infected may die and in the US about 10-15 percent of people will die.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7814851-gsk-survey-world-meningitis-day/
Moët Hennessy, Official Partner, reaffirms its support for Solar Impulse and its pursuit of the first round-the-world flight powered only by solar energy.
"Celebrating Sustainability"
Its support of Solar Impulse as an Official Partner shows Moët Hennessy's taste for pushing the envelope and conquering new territories, as well as recognizing the role of excellence and innovation as two key drivers of progress worldwide.
Growth in the Moët Hennessy group and its 22 prestigious brands has been powered by their pioneering spirit and the conquest of new territories. The first consignment of champagne was dispatched to Russia in 1780 by Veuve Clicquot. Hennessy began exporting cognac to the United States in 1787, two years before the French Revolution, followed by China in 1859. Today, Moët Hennessy exports 95% of its production and is the world's leading producer and exporter of luxury wines and spirits.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7813551-moet-hennessy-solar-impulse/
